← Leaderboards
Andy Forbes
Otsuka Pharmaceutical Development & Commercialization, Inc.
$4,023,155
Attributed
$4,023,155
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$4,023,155 · 1
By mechanism
UG3$4,023,155 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Adherence”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Martha Hering · Westat, Inc.$57,098,843
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Susan M Landau · University Of California Berkeley$47,252,026
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
- Priyamvada Acharya · Duke University$20,941,151
Research focus
AdherenceAdjuvant AnalgesicAgonistAmericanAnimalsAntidepressive AgentsAnxietyAssociated SymptomAttenuatedBuprenorphineBuprenorphine TreatmentCanis FamiliarisCombination MedicationCommon SymptomCravingDependenceDiagnosisDisorder RiskDopamineDoseDouble-Blind MethodDrug KineticsDrug Seeking BehaviorAcute Symptom